Design and Synthesis of a New Series of 4-Heteroarylamino-1'-azaspiro[oxazole-5,3'-bicyclo[2.2.2]octanes as α7 Nicotinic Receptor Agonists. 1. Development of Pharmacophore and Early Structure-Activity Relationship.

MLA

Cook, James, et al. “Design and Synthesis of a New Series of 4-Heteroarylamino-1’-Azaspiro[Oxazole-5,3’-Bicyclo[2.2.2]Octanes as Α7 Nicotinic Receptor Agonists. 1. Development of Pharmacophore and Early Structure-Activity Relationship.” Journal of Medicinal Chemistry, vol. 59, no. 24, Dec. 2016, pp. 11171–81. EBSCOhost, https://doi.org/10.1021/acs.jmedchem.6b01506.

APA

Cook, J., Zusi, F. C., McDonald, I. M., King, D., Hill, M. D., Iwuagwu, C., Mate, R. A., Fang, H., Zhao, R., Wang, B., Cutrone, J., Ma, B., Gao, Q., Knox, R. J., Matchett, M., Gallagher, L., Ferrante, M., Post-Munson, D., Molski, T., … Olson, R. E. (2016). Design and Synthesis of a New Series of 4-Heteroarylamino-1’-azaspiro[oxazole-5,3’-bicyclo[2.2.2]octanes as α7 Nicotinic Receptor Agonists. 1. Development of Pharmacophore and Early Structure-Activity Relationship. Journal of Medicinal Chemistry, 59(24), 11171–11181. https://doi.org/10.1021/acs.jmedchem.6b01506

Chicago

Cook, James, F Christopher Zusi, Ivar M McDonald, Dalton King, Matthew D Hill, Christiana Iwuagwu, Robert A Mate, et al. 2016. “Design and Synthesis of a New Series of 4-Heteroarylamino-1’-Azaspiro[Oxazole-5,3’-Bicyclo[2.2.2]Octanes as Α7 Nicotinic Receptor Agonists. 1. Development of Pharmacophore and Early Structure-Activity Relationship.” Journal of Medicinal Chemistry 59 (24): 11171–81. doi:10.1021/acs.jmedchem.6b01506.